This Newsletter covers Federal and State policy and legislative developments in the area of health. Copies of documents referred to can be obtained by clicking on the reference in this Newsletter or through Capital Monitor's collection at www.capitalmonitor.com.au or from the source quoted.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
26 October
Medicine supply to Australian communities in jeopardy if antigen testing is not provided to pharmacies
The Pharmaceutical Society of Australia (PSA) called on governments to protect the frontline healthcare workforce, and to ensure pharmacies remain open, by providing rapid antigen tests (RAT) for pharmacists and pharmacy staff. While RAT is increasingly being used by governments to manage the risk of COVID-19 in various settings like parliaments, most governments are yet to utilise these tests to protect healthcare workers such as pharmacists. PSA National President, A/Prof Chris Freeman, said that as jurisdictions come out of lockdowns, RAT must be used as part of the ongoing COVID-19 response to ensure pharmacies can remain open and communities have ongoing access to their medicines.
Download
25 October
PHI 78/21 Private Hospital Declaration
The Department of Health said that the following facility has been declared a private hospital under Section 121-5 of the Private Health Insurance Act 2007 A full list of declared hospitals with second-tier categories can be found on the Department of Health's website.
Download
Octreotide and atrioventricular block
The Therapeutic Goods Administration (TGA) said it is aware that, in Europe, atrioventricular blocks (including complete atrioventricular block) have been reported in patients receiving high doses of continuous intravenous infusion (100 micrograms/hour) of octreotide and in patients receiving bolus octreotide intravenously (50 micrograms bolus followed by 50 micrograms/hour continuous infusion). In Australia, the approved indications for octreotide do not involve intravenous administration.
Download
COVID-19 rapid antigen self-tests that are approved in Australia
The TGA approved the following COVID-19 self-tests (home use tests) for supply in Australia from 1 November 2021. Please refer to the instructions on how to use each test (that are provided in the table below) for further information on what sample types the test can be used with (e.g. nasal swab or saliva).
Download
Return to top
Research
27 October
VIC: Cancer researcher wins $1.25M CSL Centenary Fellowship
Dr Stephin Vervoort has been awarded a 2022 CSL Centenary Fellowship to fund his research to find new treatments for leukaemia and other types of cancers. Dr Stephin Vervoort will use his funding to establish a laboratory at WEHI, where he will unravel fundamental steps in transcription of DNA into mRNA. He will use that knowledge to identify new drug targets to attack acute myeloid leukaemia (AML) and other hard to treat cancers. Dr Vervoort was one of two awardees of the $1.25 million, five-year fellowships, with Associate Professor Daniel Watterson from the University of Queensland.
Download
25 October
Record female representation on new NHMRC Council
Minister for Health Greg Hunt said that the Government has announced the membership of the Council of the National Health and Medical Research Council (NHMRC). The new Council will play a key role in supporting the NHMRC in its mission of building a healthy Australia. The Council will serve a three-year term to June 2024 and will be chaired by Professor Caroline Homer AO. Membership of the Council brings together expertise in biomedical science, clinical and public health, nursing, health care training and the medical profession, as well as business and consumer perspectives, and expertise in the health needs of Aboriginal and Torres Strait Islander people.
Download
Living guidelines for clinical care of kids and teens with Covid-19
Living guidelines for the clinical care of children and adolescents with COVID-19 have been developed with 20 recommendations including the use of corticosteroids as first-line treatment for those who require oxygen. A summary of the guidelines published by the Medical Journal of Australia. Researchers from the National COVID-19 Clinical Evidence Taskforce, including panel methods lead Dr David Fraile-Navarro from Cochrane Australia at Monash University and the Centre for Health Informatics at Macquarie University, formed a Paediatric and Adolescent Care (PAC) Panel incorporating expert paediatric health practitioners from across Australia. The guidelines which will be updated in real time to give 'reliable, up-to-date advice to Australian clinicians providing paediatric care'.
Download
COVID-19 silver lining: Improving cancer care
The COVID-19 pandemic has prompted unprecedented changes in cancer care in Australia, with high-value practices across all levels set to continue post-pandemic, adding considerably to optimal cancer care, according to the authors of a consensus statement published by the Medical Journal of Australia. Cancer Australia held a virtual roundtable in July 2020 comprising thirty leading Australian cancer experts and consumers, which explored 12 elements of cancer care that have changed during the pandemic. The discussion focused on the impact of these changes, and strategies to retain, enhance, and embed high-value modifications into practice.
Download
Return to top
Rural, Regional and Remote Health
25 October
WA: Vaccine milestone for regional WA as 200,000 COVID-19 vaccines administered
WA Minister for Health Roger Cook said that the WA Country Health Service (WACHS) has administered over 200,000 vaccines to residents of rural and regional Western Australia. From Kalumburu in the State's far north to Albany in its south, clinicians are delivering the vaccine across an area spanning some 2.5 million square kilometres. The McGowan Government has been working with resource companies, industry and the Commonwealth Government to make the vaccine easier to access in regional towns. State-run COVID-19 vaccination clinics now operate across more than 100 locations, in addition to pop-up clinics being run across the State.
Download
23 October
Key rural health workforce program extended to get more medicos in the bush
Minister for Regional Health David Gillespie said that a key rural health workforce program that enables nursing and dental students and trainee doctors to train in regional and rural Australia is being extended for another three years by the Morrison Joyce Government. Federal Regional Health Minister, Dr David Gillespie said the Rural Health Multidisciplinary Training (RHMT) program provides high-quality clinical rural training experiences for students in a range of career paths, including GPs, nurses, dentists and allied health professionals. The program is another way the Federal Government is working to address the shortage of medical, nursing and allied health practitioners in rural locations.
Download
22 October
ACT: Certainty for Coombs health centre
The ACT Government will co-locate a health centre with the new Molonglo Valley Medical Centre in Coombs to deliver public health services to the Molonglo community. ACT Minister for Health Rachel Stephen-Smith said the new centre will deliver on an election commitment to co-locate with an existing general practice to provide an integrated and co-ordinated health service in the Molonglo Valley. 'The ACT Government had worked closely with the National Health Co-operative (NHC) to co-locate a walk-in health centre in Coombs before the NHC went into voluntary administration in June 2021.'
Download
Return to top
Women's Health
23 October
New help for Australians on the IVF journey
Minister for Health Greg Hunt said that the Government is giving Australians new support on their IVF journey, providing Medicare rebates for testing services that can help prevent them passing serious genetic disorders onto their child. Until now, people who know they are carriers of serious genetic disorders could only access these testing services if they were able to pay privately. From 1 November 2021, people will be able to claim a Medicare rebate for five new Medicare Benefits Schedule (MBS) items for new Pre-implantation Genetic Testing (PGT) services provided within the existing IVF process.
Download
Return to top
Transcripts
Prime Minister Scott Morrison and Minister for Health Greg Hunt
28 OCT: Transcript of Press Conference, Canberra
Subjects: COVID, Vaccination levels, Hospital system, Travel, Economy, Booster program, COP26, G20, Comprehensive Strategic Partnership, ASEAN, Digitalisation, Net zero by 2050
Department of Health
28 OCT: Transcript of Deputy Chief Medical Officer, Professor Michael Kidd's Interview with Lisa Millar, ABC News Breakfast
Subjects: Pfizer booster shots, Vaccine rollout, ATAGI, Vaccines for children, Community transmission
Department of Health
28 OCT: Transcript of Deputy Chief Medical Officer, Professor Michael Kidd's Interview with David Koch and Natalie Barr, Sunrise
Subjects: COVID booster shots, Vaccine rollout, ATAGI advice, Vaccines for children
Department of Health
28 OCT: Transcript of Deputy Chief Medical Officer, Professor Michael Kidd's Interview with Peter Stefanovic, Sky News
Subjects: Pfizer booster shots, Vaccinating young children, Vaccine dosage
Member for Newcastle Sharon Claydon
28 OCT: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: Fed Govt, Medicare cuts, GPs, Newcastle, COVID-19, Vaccine exemptions, Immunisation, Emergency departments, Hospitals
Member for Solomon Luke Gosling
28 OCT: Transcript of Interview with Katie Woolf, Mix 104.9 FM 360
Subjects: Net zero emissions by 2050, Voter ID legislation, COVID-19, Environment, Energy, Territory Rights Bill, NT, Euthanasia, Glasgow, Senate estimates
Prime Minister Scott Morrison
27 OCT: Transcript of Interview with Sabra Lane, ABC AM
Subjects: Renewable energy, Energy jobs, Power industry, Emissions reduction, Net zero target, Carbon capture & storage, Cabinet reshuffle, International tourism, Quarantine
Prime Minister Scott Morrison
27 OCT: Transcript of Interview with Karl Stefanovic, Today Show
Subjects: Vaccine booster rollout, COVID passport, International travel, Australian Open, Vaccination rates, Net zero emissions target, Energy technologies
Prime Minister Scott Morrison
27 OCT: Transcript of Interview with David Koch and Natalie Barr, Sunrise
Subjects: International travel, COVID-19 vaccination rates, Unvaccinated players at the Australian Open, Climate change, Net zero emissions, Energy technologies
Prime Minister Scott Morrison
27 OCT: Transcript of remarks to the ASEAN-Australia virtual summit
Subjects: Mental health, COVID-19, Vaccines, Foreign aid, Comprehensive Strategic Partnership, Transnational crime, Energy security, Climate change
Prime Minister Scott Morrison
27 OCT: Transcript of Interview with Neil Breen, 4BC
Subjects: Australia-US-UK alliance, Climate change, Net zero emissions, Energy policy, Federal Budget, International travel, Quarantine, Vaccine booster shots
Assistant Minister to the PM on Mental Health David Coleman
27 OCT: Transcript of Interview with Leon Byner, FIVEaa
Subjects: Privacy legislation, Impact of social media, Mental health, Social media companies, Young consumers
Minister for Health Greg Hunt, Therapeutic Goods Administration (TGA)
27 OCT: Transcript of Press Conference with Professor John Skerritt, Canberra
Subjects: TGA approves Pfizer booster shot roll out, Vaccination shots prepared for 5-11 year olds, Rapid COVID tests
Minister for Health Greg Hunt
27 OCT: Transcript of Press Conference, Canberra
Subjects: TGA, Pfizer, Booster Shots, COVID-19, Disability sectors, Vaccination certificates, Rapid antigen tests, Pharmacies, Vaccines for children, International travel
Minister for Health Greg Hunt
27 OCT: Transcript of Interview with Jim Wilson, 2GB Drive
Subjects: Booster shots, Rapid antigen tests, Quarantine policy, Sport, TGA, Pfizer, COVID-19, AstraZeneca, Moderna, Chief Medical Officer, Public health, Vaccination
Minister for Health Greg Hunt
27 OCT: Transcript of Interview with Kieran Gilbert, Sky News Afternoon Agenda
Subjects: Booster shots, Rapid antigen testing, Emissions reduction, Climate change, Vaccine supply, International travel, Mandatory vaccination, Quarantine
Minister for Regional Health David Gillespie
27 OCT: Transcript of Interview with Jaynie Seal, Sky News Regional
Subjects: Regional hospitals in crisis, Doctors shortage, Health system, Obsteric services in hospitals, Hospital services
Minister for Employment, Workforce, Skills, Small and Family Business Stuart Robert
27 OCT: Transcript of Interview with Karl Stefanovic, Today Show
Subjects: Net zero emissions by 2050, Emissions reduction policy, TGA approval for boosters, Vaccine rollout, Home affairs, AFP conduct
Shadow Minister for Health and Ageing Mark Butler
27 OCT: Transcript of Doorstop Interview, Adelaide
Subjects: COVID-19, Hospitals, Public health, Booster shots, Vaccination, Immunisation, Hospital system modelling, TGA, ATAGI, Frontline health workers
Member for McQuarie Susan Templeman
27 OCT: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: Climate change, Net zero emissions, COVID-19 testing, Rapid antigen self-testing
Shadow Minister for Northern Australia Murray Watt
26 OCT: Transcript of Interview with Tom Connell, Sky News
Subjects: Anti-vax propaganda, Anti-vax MPs, Vaccine rollout, Net zero emissions, TGA, Vaccine related deaths, QLD vaccine rates
Shadow Minister for Industry and Innovation Ed Husic
26 OCT: Transcript of Interview with Patricia Karvelas, ABC Afternoon Briefing
Subjects: mRNA manufacturing timeline, Vaccine production, Net zero 2050 target, Emissions reduction, Climate change
Prime Minister Scott Morrison
25 OCT: Transcript of Virtual Remarks, ASEAN Business and Investment Summit 2021
Subjects: Foreign relations, Indo-Pacific, Vaccine supply, Quad partnership, Investment in energy transition, Net Zero Emissions target
Minister for Mental Health David Coleman
25 OCT: Transcript of Interview with Deb Knight, 2GB
Subjects: Legislation, Mental health, COVID-19, Social media regulation, Protecting youth, Facebook, Online privacy, Data brokers, Social media algorithms
Minister for Health Greg Hunt
24 OCT: Transcript of Press Conference, Canberra
Subjects: Vaccination rates, PR Campaign, Climate change, Indigenous Australian, Breast cancer treatment, Verzenio, IVF, Medicare, Mackenzie's Mission
Department of Health
23 OCT: Transcript of Press Conference by Deputy Chief Medical Officer Professor Michael Kidd
Subjects: Vaccine rollout, Vaccination centres, Access to vaccines for remote communities, Booster doses, ATAGI advice, Novavax
Return to top
Reports
COVID-19 Mortality
Australian Bureau of Statistics (ABS)
920 deaths due to COVID-19 that occurred by 31 July 2021 have been registered and received by the ABS. The ABS expects to receive further registrations for this period from the jurisdictional Registries of Births, Deaths and Marriages.
Download
Provisional Mortality Statistics
Australian Bureau of Statistics (ABS)
In 2021, 85,392 deaths occurred by 31 July and were registered by 30 September. Counts of deaths were above historical averages while rates were below average for each month of 2021. 920 people died of COVID-19, with dementia being the most common pre-existing chronic condition.
Download
NATIONAL DISABILITY INSURANCE AGENCY NDIA: Annual Report 2020-21
Return to top
Hansards
Federal
28 OCT 2021: REPS HANSARD: Federation Chamber - Adjournment - National Disability Insurance Scheme
28 OCT 2021: REPS HANSARD: Federation Chamber - Constituency Statements - Banking and Financial Services - Health Care
28 OCT 2021: REPS HANSARD: Federation Chamber - Constituency Statements - COVID-19: Vaccinations
28 OCT 2021: REPS HANSARD: Statements By Members - COVID-19: Vaccination
28 OCT 2021: REPS HANSARD: Statements By Members - COVID-19: Immigration Detention
28 OCT 2021: REPS HANSARD: Bills - National Disability Insurance Scheme Amendment (Participant Service Guarantee and Other Measures) Bill 2021 - First Reading, Second Reading, Debate Adjourned
28 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19: Indi Electorate
28 OCT 2021: REPS HANSARD: Bills - National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Bill 2021 - First Reading, Second Reading, Debate Adjourned
28 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
27 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19: National Plan
27 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19
27 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
27 OCT 2021: REPS HANSARD: Adjournment - COVID-19: Vaccination
27 OCT 2021: REPS HANSARD: Statements By Members - Paterson Electorate: Maitland Hospital
27 OCT 2021: REPS HANSARD: Statements By Members - The Glen Drug and Alcohol Rehabilitation Centre
27 OCT 2021: REPS HANSARD: Statements By Members - Western Sydney: COVID-19
25 OCT 2021: REPS HANSARD: Adjournment - Abdominoplasty Surgery
25 OCT 2021: REPS HANSARD: Statements by Members - Mental Health
25 OCT 2021: REPS HANSARD: Federation Chamber - Statements by Members - Moore Electorate: Health Care
25 OCT 2021: REPS HANSARD: Statements by Members - Flynn Electorate: Indigenous Health
25 OCT 2021: REPS HANSARD: Federation Chamber - Constituency Statements - du Plessis, Dr Charl - O'Connor Electorate: Health and Emergency Service Workers
25 OCT 2021: REPS HANSARD: Bills - Aged Care and Other Legislation Amendment (Royal Commission Response No. 2) Bill 2021 - Debate Resumed, Second Reading, Consideration in Detail, Third Reading
25 OCT 2021: REPS HANSARD: Federation Chamber - Statements by Members - COVID-19: Vaccination
25 OCT 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
25 OCT 2021: REPS HANSARD: Petitions - Responses - 21 Requests for Action
ACT
20 OCT 2021: ACT ASSEMBLY HANSARD: Estimates - Inquiry into ACT Budget 2021-22 - Standing Committee On Health And Community Wellbeing - ACT Health - Canberra Health Services
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Health Care Consumers Association of the ACT - Opening Statement
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Health Care Consumers Association of the ACT
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Ted Noffs Foundation 1
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Alcohol Tobacco and Other Drug Association ACT
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Ted Noffs Foundation - Opening Statement
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Advocacy for Inclusion
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Alcohol Tobacco and Other Drug Association ACT - Opening Statement
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Advocacy for Inclusion - Opening Statement
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Foundation for Alcohol Research and Education - Opening Statement
28 SEP 2021: ACT ASSEMBLY HANSARD: Estimates - Review of ACT health programs for children and young people - Standing Committee on Health and Community Wellbeing - Foundation for Alcohol Research and Education
NSW
21 OCT 2021: NSW COUNCIL HANSARD: Adjournment Debate - COVID-19 and Parliamentary sittings
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Banksia Mental Health Unit
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - Suicide prevention
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Suicide prevention
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - COVID-19 and Senior Citizens
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - Banksia Mental Health Unit
21 OCT 2021: NSW COUNCIL HANSARD: Documents - COVID-19 and Correctional Facilities - COVID-19 Health Advice - Sydney Science Park Water Services - Variation of Order
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Suicide prevention
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Banksia Mental Health Unit
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - Suicide prevention
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - COVID-19 and Senior Citizens
21 OCT 2021: NSW COUNCIL HANSARD: Questions Without Notice - Banksia Mental Health Unit
21 OCT 2021: NSW ASSEMBLY HANSARD: Private Members' Statements - COVID-19 and Goulburn Electorate
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Maitland Health Stays
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Yagoona Family Healthcare
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Local Pharmacist and Doctors - Part 1
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Local Pharmacists and Doctors - Part 2
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Local Pharmacists and Doctors
21 OCT 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Bankstown Family Medical Practice
21 OCT 2021: NSW ASSEMBLY HANSARD: Petitions - Central Coast COVID-19 Vaccinations
21 OCT 2021: NSW ASSEMBLY HANSARD: Question Time - COVID-19 and Regional New South Wales
21 OCT 2021: NSW ASSEMBLY HANSARD: Question Time - COVID-19 and Disability Support Services
Northern Territory
28 OCT 2021: NT ASSEMBLY HANSARD: Bills - Medicines, Poisons And Therapeutic Goods Legislation Amendment Bill 2021 - Introduction, First Reading, Second Reading, Debate Adjourned
28 OCT 2021: NT ASSEMBLY HANSARD: Supplementary Question - Health System for Border Opening
28 OCT 2021: NT ASSEMBLY HANSARD: Question Time - Disability Sector Opportunities
27 OCT 2021: NT ASSEMBLY HANSARD: Petition - Petition No 11 - Opposing COVID-19 Vaccination Mandates
27 OCT 2021: NT ASSEMBLY HANSARD: Bills - Termination Of Pregnancy Law Reform Legislation Amendment Bill 2021 - First Reading, Second Reading
Queensland
28 OCT 2021: QLD ASSEMBLY HANSARD: Adjournment - Coronavirus, Vaccination
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Hospitals, Access
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Redcliffe Hospital
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Hospitals, Bed Capacity
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Hospitals, Demand
28 OCT 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Vaccination
28 OCT 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Vaccination; World Teachers' Day
28 OCT 2021: QLD ASSEMBLY HANSARD: Ministerial Statements - Coronavirus, Update
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Vaccination
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Minister for Health and Ambulance Services
28 OCT 2021: QLD ASSEMBLY HANSARD: Questions Without Notice - Coronavirus, Tourism Industry
28 OCT 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Burdekin Electorate, Vaccination
28 OCT 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Mental Health Week
28 OCT 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Sexual Violence Awareness Month; Health Services; Coronavirus, Vaccination
28 OCT 2021: QLD ASSEMBLY HANSARD: Private Members' Statements - Health System
Tasmania
14 OCT 2021: TAS ASSEMBLY HANSARD: Answer to Question - COVID-19 - Royal Hobart Hospital and Positive Case
14 OCT 2021: TAS ASSEMBLY HANSARD: Questions - COVID-19 - Royal Hobart Hospital and Positive Casel
13 OCT 2021: TAS ASSEMBLY HANSARD: Questions - COVID-19 - Mental Health
12 OCT 2021: TAS ASSEMBLY HANSARD: Questions - COVID-19 - Workforce Shortages in Health System
12 OCT 2021: TAS ASSEMBLY HANSARD: Questions - COVID-19 - Health Funding from Commonwealth Government
13 OCT 2021: TAS ASSEMBLY HANSARD: Motion - Mental Health and Wellbeing of Young People
Victoria
27 OCT 2021: VIC ASSEMBLY HANSARD: Members Statements - COVID-19
27 OCT 2021: VIC ASSEMBLY HANSARD: Adjournment - COVID-19
27 OCT 2021: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - Ministers Statements: COVID-19 Vaccinations
27 OCT 2021: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - COVID-19
27 OCT 2021: VIC ASSEMBLY HANSARD: Questions Without Notice and Ministers Statements - COVID-19
27 OCT 2021: VIC ASSEMBLY HANSARD: Petitions - Breast Screening
27 OCT 2021: VIC ASSEMBLY HANSARD: Adjournment - COVID-19 Vaccinations
27 OCT 2021: VIC ASSEMBLY HANSARD: Bills - Public Health and Wellbeing Amendment (Pandemic Management) Bill 2021 - Statement of Compatibility, Second Reading, Debate Adjourned
27 OCT 2021: VIC COUNCIL HANSARD: Questions Without Notice and Ministers Statements - COVID-19 Vaccination
27 OCT 2021: VIC COUNCIL HANSARD: Adjournment - COVID-19 Vaccination
27 OCT 2021: VIC COUNCIL HANSARD: Members Statements - COVID-19
27 OCT 2021: VIC COUNCIL HANSARD: Adjournment - Shepparton Paediatric Services
27 OCT 2021: VIC COUNCIL HANSARD: Petitions - COVID-19
27 OCT 2021: VIC COUNCIL HANSARD: Members Statements - COVID-19 Vaccination
27 OCT 2021: VIC COUNCIL HANSARD: Adjournment - Eltham Community Hospital
Western Australia
28 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Vaccinations - Access
28 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Care Centre Model
28 OCT 2021: WA ASSEMBLY HANSARD: Grievance - Health Services - Midwest And Wheatbelt
28 OCT 2021: WA ASSEMBLY HANSARD: Bills - Health Services Amendment Bill 2021 - Second Reading, Debate Adjourned
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccination Plan - Regions
28 OCT 2021: WA COUNCIL HANSARD: Notice of Motion - Medical Privacy
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Wyndham Hospital - Staff
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Mandatory Quarantine
28 OCT 2021: WA COUNCIL HANSARD: Question on Notice 289 - Answer Advice - Hospitals - Regions - Staff
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Schools - Ventilation
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Schools - Ventilation
28 OCT 2021: WA COUNCIL HANSARD: Question without Notice 802 - Answer Advice - Health Worker (Restrictions On Access) Directions
28 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccine Commander
27 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Vaccinations
27 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Vaccinations - Target
27 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - State Economy
27 OCT 2021: WA ASSEMBLY HANSARD: Statement by Minister for Disability Services - Access Culinary Course - Graduation
27 OCT 2021: WA ASSEMBLY HANSARD: Statement by Minister for Disability Services - International Day of People with Disability
27 OCT 2021: WA ASSEMBLY HANSARD: Questions Without Notice - Coronavirus - Intensive Care Units - Surge Capacity
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Healthcare Workforce - Morale
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccinations - Department of Fire and Emergency Services Volunteers
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccinations
27 OCT 2021: WA COUNCIL HANSARD: Statement - Sir Charles Gairdner Hospital - Emergency Department
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus - Vaccinations
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Education - Periods, Pain and Endometriosis Program
27 OCT 2021: WA COUNCIL HANSARD: Questions Without Notice - Geraldton Health Campus - Staff
Return to top
Court Cases
None this edition.
Return to top
New Regulations
Federal
Therapeutic Goods Legislation Amendment (2021 Measures No. 3) Regulations 2021
Legislative Instrument - F2021L01474
The purpose of the Therapeutic Goods Legislation Amendment (2021 Measures No. 3) Regulations 2021 (the Regulations) is to amend the Therapeutic Goods Regulations 1990 (the TG Regulations) and the Therapeutic Goods (Medical Devices) Regulations 2002 (the MD Regulations), principally to reduce regulatory burden for sponsors and manufacturers of medical devices (e.g. by exempting surgical loan kits from the requirement to be included in the Australian Register of Therapeutic Goods (the Register)), and improve access to unapproved medicines for the treatment of seriously ill patients.
Explanatory Statement
Therapeutic Goods (Prescription Medicines-Information Accompanying Applications for Registration) Determination 2021
Legislative Instrument - F2021L01466
The Therapeutic Goods Amendment (2017 Measures No.1) Act 2018 ('the Amendment Act') amended the Act to, among other things, provide greater clarity in relation to the preliminary assessment of applications for the inclusion of therapeutic goods in the Australian Register of Therapeutic Goods ('the Register'). In particular, the Amendment Act introduced measures to require an application for the inclusion of a medicine, biological or medical device in the Register to meet certain preliminary requirements before the Secretary may proceed to evaluation. The Amendment Act also provided the Secretary with the power to refuse an application prior to evaluation if the application does not meet those requirements.
Explanatory Statement
Biosecurity (Human Coronavirus with Pandemic Potential) Amendment (No. 2) Determination 2021
Legislative Instrument - F2021L01463
The Amendment Determination amends the Determination to include an automatic exemption for fully vaccinated Australian citizens and permanent residents to depart Australian territory, provided they meet the specified criteria. 'Fully vaccinated' means that a person has been vaccinated with a vaccine that is registered on the Australian Register of Therapeutic Goods or is recognised by Australia's Therapeutic Goods Administration.
Explanatory Statement
Biosecurity Legislation Amendment (Incoming International Flights) Determination 2021
Legislative Instrument - F2021L01462
The Amendment Determination establishes further exemptions for specified classes of persons from the testing requirements set out in the Emergency Requirements Determination and the Preventative Biosecurity Measures Determination, and requires medical certificates to be provided within a specified time frame for the purposes of the relevant exemptions set out in the Emergency Requirements Determination. This ensures that the certificates are current for a person before they undertake a relevant international flight (or connecting flight) into Australian territory.
Explanatory Statement
Private Health Insurance Legislation Amendment Rules (No. 6) 2021
Legislative Instrument - F2021L01461
The Amendment Rules make consequential amendments to the Benefit Requirements Rules and the Complying Product Rules to implement changes to the private health insurance clinical categorisations and procedure type classification of items of the Medicare Benefits Schedule (MBS) to reflect changes to MBS items that take effect from 1 November 2021.
Explanatory Statement
Return to top
Proclamations
None this edition.
Return to top
Gazette Notices
None this edition.
Return to top
Consolidated Legislation
Federal
Therapeutic Goods (Manufacturing Principles) Determination 2020
Legislative Instrument Compilation - F2021C01074
Determinations/Health as amended, taking into account amendments up to Therapeutic Goods (Consequential Amendments-TGO 108) Instrument 2021.
Download
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021
Legislative Instrument Compilation - F2021C01071
PB 84 of 2021 Determinations/Health as amended, taking into account amendments up to National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2021.
Download
National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Determination 2017
Legislative Instrument Compilation - F2021C01068
PB 81 of 2017 Determinations/Health as amended, taking into account amendments up to National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination 2021 (No. 4).
Download
National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019
Legislative Instrument Compilation - F2021C01066
PB 114 of 2019 Determinations/Health as amended, taking into account amendments up to National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2021 (No. 8).
Download
National Health (Continued Dispensing - Emergency Measures) Determination 2020 Authoritative Version
Legislative Instrument Compilation - F2021C01054
Determinations/Health as amended, taking into account amendments up to National Health (Continued Dispensing - Emergency Measures) Amendment Determination 2021 (No. 9).
Download
National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 Authoritative Version
Legislative Instrument Compilation - F2021C01052
PB 79 of 2011 Arrangements as amended, taking into account amendments up to National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2021 (No. 9).
Download
National Health (Listed Drugs on F1 or F2) Determination 2021 Authoritative Version
Legislative Instrument Compilation - F2021C01051
PB 33 of 2021 Determinations/Health as amended, taking into account amendments up to National Health (Listed Drugs on F1 or F2) Amendment Determination 2021 (No. 7).
Download
National Health Act 1953
Act Compilation - C2021C00460
Act No. 95 of 1953 as amended, taking into account amendments up to National Health Amendment (COVID-19) Act 2021 An Act relating to the provision of pharmaceutical, sickness and hospital benefits, and of medical and dental services.
Download
National Health Security Act 2007 Authoritative Version
Act Compilation - C2021C00451
Act No. 174 of 2007 as amended, taking into account amendments up to Federal Circuit and Family Court of Australia (Consequential Amendments and Transitional Provisions) Act 2021 An Act to provide for national health security, and for related purposes.
Download
Return to top
New Bills
Federal
A Private Member's Bill (Sharkie) for an Act to amend the Aged Care Act 1997, and for related purposes.
The purpose of the Bill is to put in place a fairer fee structure for aged care at home, and thus to better inform, and serve, older Australians, their families, carers and the taxpayer. The Royal Commission into Aged Care Quality and Safety noted that for a $52,000, level 4, home care package, a recipient received on average only 8 hours and 45 minutes of support per week.
High administration and management fees charged for aged care provided in the recipient's home have not resulted in better payments to aged care workers, who receive hourly rates reportedly 25 per cent lower than those of people undertaking comparable duties in the disability sector.
The Bill will define which costs can be included by providers under 'administration and management' fees, and cap the proportion of fees that may be charged as administration and management fees to no more than 25 per cent of fees under a Level 1 and or Home Care package and no more than 20 per cent of a Level 3 or 4 package. It is not intended to impact hourly rates of pay received by workers in aged care.
Administration or management fees will need to be set and identified separately from the rest of home care fees to prevent such fees from being 'hidden' in inflated hourly costs. Administration and management fees will be defined as including administration staff, insurance, workers' compensation, case management or care coordination and budget preparation.
The Bill will ban home care providers from charging 'exit fees' which practice limits a person's choices to change their home care provider if they are not satisfied with the care provided or fees charged. This will improve the autonomy of older Australians who may wish to change providers or indeed to move to self-management of the care they receive in their homes.
Providers will be required to give to a prospective care recipient a schedule setting out the home care fees charged by at least five other approved providers in the area, or if there are fewer than five other such home care providers in the area, the schedule must set out the fees of all other approved home care providers in the area. This will make comparative pricing information more accessible to prospective recipients of care at the time when they are deciding whether or not to enter into an aged care agreement, so that they may make an informed choice of care provider and the terms on which that care is delivered.
The Bill will thus improve the autonomy of aged care recipients, and provide them with the relevant information, putting them at the heart of decisions about the care they receive in their own homes.
Reps: Intro 25/10/21, 2R 25/10/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act: a single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
A Bill for an Act to amend the law relating to aged care, health and aged care pricing, and information sharing in relation to veterans and military rehabilitation and compensation, and for related purposes
Schedule 1 amends the Aged Care Act 1997 (Aged Care Act) and the Aged Care (Transitional Provisions) Act 1997 (Transitional Act) to enable the introduction of a new residential aged care basic subsidy calculation model, the Australian National Aged Care Classification (AN-ACC). This model will replace the Aged Care Funding Instrument from 1 October 2022. The new funding model will link calculation of a variable amount of residential aged care subsidy to each care recipient's AN-ACC level. It will also link calculation of a fixed amount of subsidy to the characteristics of residential aged care services. This fixed component will be the same for all residents at a service and will be higher for services in remote locations and certain specialist services, in recognition of higher fixed operating costs.
Schedule 2 of the Bill amends the Aged Care Act and the Aged Care Quality and Safety Commission Act 2018 (Quality and Safety Commission Act) to establish the legislative authority for nationally consistent pre-employment screening for aged care workers of approved providers to replace existing police checking obligations.
Schedule 3 of the Bill amends the Aged Care Act and the Quality and Safety Commission Act to allow the Aged Care Quality and Safety Commissioner (Commissioner) to make and enforce a Code of Conduct (Code) that will apply to approved providers and their workers, including governing persons. It will give the Commissioner powers to deal with information received about alleged breaches of the Code, and take enforcement actions for substantiated breaches.
Schedule 4 of the Bill amends the Aged Care Act to extend the Serious Incident Response Scheme (SIRS) from residential care to home care and flexible care delivered in a home or community setting from 1 July 2022. This Schedule introduces new responsibilities for approved providers of home care, and flexible care delivered in a home or community setting to manage incidents, including through implementing and maintaining an incident management system that complies with requirements set out in the Quality of Care Principles 2014.
The definition of a reportable incident will also be extended to home and community care settings, so that home care and flexible care providers operating in these settings will be required to notify the Commissioner of these incidents. Protections against retribution or vilification for individuals reporting such incidents will also extend to reportable incidents in these settings.
Schedule 4 of the Bill will also amend the Quality and Safety Commission Act to expand the Commissioner's powers to deal with incidents that are reported by Commonwealth grant funded aged care service providers, and authorise these providers to collect, use and disclose information relevant to their obligations in relation to the SIRS for the purposes of the Privacy Act 1988.
Schedule 5 of the Bill amends the Aged Care Act and the Quality and Safety Commission Act to improve the governance of approved providers of aged care. From 1 March 2022, the amendments will introduce new governance responsibilities for approved providers in relation to the membership of their governing bodies and the establishment of new advisory bodies, as well as measures to improve leadership and culture. These measures are aimed at improving transparency and accountability, and ensuring the focus of approved providers, from the top down, is on the best interests of care recipients.
Schedule 5 also introduces new reporting responsibilities for approved providers, including to provide an annual statement on their operations that will be made publicly available. This will help care recipients and their families understand key details of providers, including information about financial circumstances, staffing levels and complaints. The amendments will also require approved providers to notify the Commission of changes to key personnel and will replace the current disqualified individual arrangements with a suitability test for key personnel, consistent with the arrangements under the National Disability Insurance Scheme (NDIS).
Schedule 6 of the Bill amends the Aged Care Act, the Quality and Safety Commission Act, Veterans' Entitlements Act 1986, the Military Rehabilitation and Compensation Act 2004, and the Safety, Rehabilitation and Compensation (Defence-related Claims) Act 1988 to facilitate greater information sharing between Commonwealth bodies across the aged care, disability and veterans' affairs sectors in relation to noncompliance of providers and their workers.
Schedule 7 of the Bill amends the Aged Care Act to enable the Secretary or Commissioner to request information or documents from a provider or borrower of a loan made using a refundable accommodation deposit or bond. The amendments create an offence for a borrower who does not comply with a request. Further, the period of liability for the existing offences for the misuse of refundable accommodation deposits prior to an insolvency event for both providers and key personnel of providers will be extended from 2 years to 5 years.
Schedule 7 also amends the Quality and Safety Commission Act to enable the Commissioner to issue an infringement notice for a borrower who commits an offence for failing to comply with a request under these amendments. The reforms implemented under Schedule 7 of the Bill will form part of the second phase of a three phase plan to implement a new financial and prudential monitoring, compliance and intervention framework for the aged care sector.
Schedule 8 to the Bill amends the National Health Reform Act 2011 (National Health Reform Act) and the Aged Care Act to expand the functions of a renamed Independent Health and Aged Care Pricing Authority (Pricing Authority) to include the provision of advice on health care pricing and costing matters, provision of advice on aged care pricing matters and the performance of certain functions conferred in the Aged Care Act. The amendments also establish new governance arrangements and appointments processes for the Pricing Authority. The new governance and appointment arrangements will reflect the enhanced responsibilities and integrated functions of the Pricing Authority and streamline its administration.
Schedule 8 also amends the National Health Reform Act, the Aged Care Act and the Quality and Safety Commission Act to ensure appropriate use and disclosure of information required for the Pricing Authority to perform its new functions.
On 21 October 2021, the Senate Selection of Bills Committee referred the provisions of the Bill to to the Community Affairs Legislation Committee for inquiry and report by 16 November 2021.
Reps: Intro 01/09/21, 2R 01/09/21, 20/10/21, 25/10/21, Passed (with 14 Government amendments) 25/10/21
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - 1 October 2022.
- Schedule 2 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 12 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
- Schedule 3 - 1 July 2022.
- Schedule 4, Part 1 - 1 July 2022.
- Schedule 4, Part 2 - The day after this Act receives the Royal Assent.
- Schedule 5 - 1 March 2022.
- Schedule 6 - The day after this Act receives the Royal Assent.
- Schedule 7 - 1 July 2022.
- Schedule 8 - The 28th day after this Act receives the Royal Assent.
A Bill for an Act to amend the Health Insurance Act 1973, and for related purposes
This Bill amends the Health Insurance Act 1973 (the Act) to implement improvements to the Bonded Medical Program (the Program) established under Part VD of the Act and to the administration of Medical Rural Bonded Scholarship (MRBS) contracts under section 19 of the Act.
The Government is committed to better distributing the medical workforce to regional, rural and remote communities, which on average have less access to doctors than people in metropolitan areas.
The Program provides a Commonwealth-supported place in a course of study in medicine at an Australian university in exchange for a participant completing a Return of Service Obligation (RoSO) working as a doctor in a regional, rural or remote community.
The Program commenced on 1 January 2020, replacing legacy contract-based schemes with new, simpler arrangements. In 2020 and 2021, new medical students at Australian universities have entered into this new Program. It is intended that participants in two legacy schemes, the MRBS Scheme and the Bonded Medical Places (BMP) Scheme can decide whether to opt in to the Program.
Amending the Act will provide the flexibility necessary to enhance implementation of the Program. The proposed amendments will address unintended consequences in the interests of participants and will also support achievement of the Commonwealth's Program objectives.
Reps: Intro 26/08/21, 2R 26/08/21, 18/10/21, 26/10/21, Passed 26/10/21
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
- Schedule 2 - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the National Disability Insurance Scheme Act 2013, and for related purposes.
This Bill amends the Act to enable the Minister to make NDIS Rules in a legislative instrument setting out the Participant Service Guarantee (the Guarantee) and, streamline administrative process to improve the participant experience. The Bill also amends the Act to reflect the availability of the National Disability Insurance Scheme across Australia by removing concepts related solely to launch and transition
The Bill gives effect to several of the recommendations of the 2019 Independent Review of the Act undertaken by Mr David Tune AO PSM (the Tune Review), including the Guarantee to provide timeframes and engagement principles for how the National Disability Insurance Agency (the Agency) undertakes key administrative processes.
The provisions in the Bill do not alter the fundamental principles and objectives of the Act, the NDIS as a service system, the roles and responsibilities of all governments in the governance of the scheme, or the legislated functions of the Agency in delivering the NDIS.
Reps: Intro 28/10/21, 2R 28/10/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table: the day this Act receives the Royal Assent.
- Schedule 1, item 1: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 2 and 3: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 4 to 12: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 13: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, item 14: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 15: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, item 16: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 17 to 29: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, item 30: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 31 to 33: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 34 to 36: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 37: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, item 38: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 39: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, item 40: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 41: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 42 and 43: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 44 to 51: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 52 to 57: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 58: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 59 and 60: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 61 and 62: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 63 and 64: the seventh day after this Act receives the Royal Assent.
- Schedule 1, item 65: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 66 and 67: the seventh day after this Act receives the Royal Assent.
- Schedule 1, items 68 and 69: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 1, items 70 and 71: the seventh day after this Act receives the Royal Assent.
- Schedule 2: the later of:
- the day after the end of the period of 3 months beginning on the day this Act receives the Royal Assent; and
- 1 April 2022.
- Schedule 3: the seventh day after this Act receives the Royal Assent.
A Bill for an Act to amend the National Disability Insurance Scheme Act 2013, and for related purposes
The NDIS Act 2013 (the NDIS Act) provides a foundation for measures to support and protect NDIS participants at risk of harm. This Bill amends various provisions in the NDIS Act to improve the support and protections provided to NDIS participants who may be at risk of harm.
Following recent cases of abuse, neglect and exploitation of NDIS participants, the Government has considered a number of inquiries the effectiveness of NDIS safeguards in these cases, in addition to the Hon. Alan Robertson SC Independent Review of the adequacy of the regulation of the supports and services provided to Ms Ann- Marie Smith, an NDIS Participant, who died on 6 April 2020 (the Robertson Review), commissioned by the NDIS Commissioner.
The Bill will strengthen support and protections for people with disability by ensuring a clear and effective legislative basis for the NDIS Quality and Safeguards Commissioner's (Commissioner's) powers, compliance and enforcement arrangements, provider registration provisions and efficient information sharing across governments and government agencies.
On 17 Jun 2021, the Senate Selection of Bills Committee referred the Bill to the Community Affairs Legislation Committee for inquiry and report by 12 August 2021.
Reps: Intro 03/06/21, 2R 03/06/21, 23/08/21, 24/08/21, 25/08/21, Passed 25/08/21
Senate: Intro 26/08/21, 2R 19/10/21, 20/10/21, Passed 21/10/21
Assent 28/10/21, Act No. 116 of 2021.
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the National Health Act 1953, and for other purposes.
This Bill amends the National Health Act 1953 to implement measures negotiated in new Strategic Agreements with Medicines Australia and the Generic and Biosimilar Medicines Association acting on behalf of the medicines industry in Australia. These measures relate to supply of medicines listed on the Pharmaceutical Benefits Scheme (PBS) and arrangements for statutory price reductions to the PBS price (the AEMP) of PBS listed brands. The measures are intended to:
- generate savings to be reinvested in the PBS to support subsidy of the continuously growing treatment options for patients; and
- mitigate the impact of global medicines shortages on the ability for patients to access PBS listed medicines in Australia.
The measures do this by improving statutory price reductions for PBS medicines and, at the same time, preventing the prices of PBS medicines from being reduced below what is needed to support reliable supply, and introducing a requirement that pharmaceutical companies that supply older and low cost medicines that are more susceptible to global supply disruptions hold greater stocks of those medicines in Australia.
Reps: Intro 28/10/21, 2R 28/10/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table: the day this Act receives the Royal Assent.
- Schedule 1, Part 1: the day after this Act receives the Royal Assent.
- Schedule 1, Part 2: 1 July 2022.
- Schedule 1, Part 3: 1 October 2022.
- Schedule 1, Part 4: 1 July 2023.
- Schedule 1, Part 5: 1 July 2027.
Northern Territory
A Bill for an Act to amend the Medicines, Poisons and Therapeutic Goods Act 2012 and the Medicines, Poisons and Therapeutic Goods Regulations 2014
The purpose of this Bill is to allow the Northern Territory to implement a Real Time Prescription Monitoring system. Real Time Script Monitoring provides relevant prescribers and pharmacists with information about a patient's history and use of monitored medicines at the time of issuing a prescription or supplying the medicine. The real time patient information supports prescribers and pharmacists in making clinical decisions about appropriate medication use, which can reduce overuse or misuse of medication and risk of accidental deaths.
Notice of Motion 27/10/21
Intro 28/10/21, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act commences on the day after the day on which the Administrator's assent to this Act is declared.
A Bill for an Act to amend the Termination of Pregnancy Law Reform Act 2017, the Termination of Pregnancy Law Reform Regulations 2017 and the Criminal Code
The purpose of this Bill is to further improve safe access to reproductive choice for women in the Northern Territory. The Bill removes the need for assessment by a second doctor for terminations up to 24 weeks; increases the gestational upper limit from 23 to 24 weeks; allows terminations after 24 weeks gestation following consultation between two medical practitioners; removes additional credentialing requirements for medical practitioners who perform termination of pregnancy over their existing credentialing; and makes a consequential amendment to the Criminal Code.
Notice of Motion 26/10/21
Intro 27/10/21, 2R 27/10/21, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act commences on the day after the day on which the Administrator's assent to this Act is declared.
South Australia
A Bill for An Act to amend the Health Practitioner Regulation National Law (South Australia) Act 2010.
The purpose of this bill is to make permanent the legal provisions for the authorising of telepharmacy in South Australia. Similar temporary provisions were supported by members as part of the COVID-19 Emergency Response (Further Measures) (No.2) Amendment Bill 2020. These provisions were extended with the passage of the COVID-19 Emergency Response (Expiry and Rent) Amendment Bill 2020 and are set to expire on 6 February 2021. This Bill includes two additional provisions to those included in the temporary COVID-19 Acts.
Firstly, PRASA may only authorise the provision of telepharmacy services where the authorisation is necessary to ensure that pharmacy services are available to people who otherwise would not have direct and timely access to these services. This addresses any perceived potential for new business models for routine delivery of pharmacy services. Secondly, a pharmacy services provider must ensure that a relevant code of conduct is complied with when providing services remotely. The Pharmacy Regulation Authority of South Australia has developed a code of conduct for this purpose.
LC: 1R 15/10/20, 2R 15/10/20, 03/12/20, 26/08/21, Passed 26/08/21
LA: 1R 26/08/21, 2R 26/10/21, Passed 26/10/21
LC: Final Stages 26/08/21
Assent TBA, Act No. TBA
Commencement: This Act comes into operation on a day to be fixed by proclamation.
Tasmania
A Bill for An Act to repeal the Alcohol and Drug Dependency Act 1968 and to amend certain Acts, and rescind or revoke certain legislative instruments, consequent on that repeal.
The purpose of this Bill is to repeal legislation that is out of date and unnecessary.
This Bill repeals the Alcohol and Drug Dependency Act 1968 (the ADDA) and subordinate regulations and orders. It also makes minor consequential amendments to definitions in the Community Protection (Offender Reporting) Act 2005, the Poisons Act 1971, and the Road Safety (Alcohol and Drugs) Act 1970.
In its current form, the ADDA provides for the admission and detention of persons to a treatment centre; establishes a tribunal with limited review powers; and allows for the designation of treatment centres and appointment of superintendents and welfare officers.
The ADDA's use has been in steady decline and it has not been used at all since early 2016. The Tribunal has received only two applications in the last 18 years, with the last being received in 2009.
LA: Intro 01/09/21, 2R 12/10/21, Passed 12/10/21
LC: Intro 15/10/21, 2R 28/10/21, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act commences on a day to be proclaimed.
Victoria
A Bill for an Act to amend the Public Health and Wellbeing Act 2008 in relation to the effective management of pandemics and for other purposes.
The Bill will establish a contemporary, fit-for-purpose regulatory framework to enable the effective management of pandemics, including the current COVID-19 pandemic. The Bill will introduce amendments to enable the protection of public health from the serious threat posed by pandemic diseases and diseases of pandemic potential. Most critically, the Bill focuses on saving Victorian lives during pandemics, and promoting and protecting the social, economic and mental welfare of Victorians to the greatest extent possible during these confronting events.
The Bill amends Victoria's principal public health statute, the Public Health and Wellbeing Act 2008, primarily by inserting a new Part 8A-Protection of life and public health during pandemics. The main objective of the new Part is to protect public health and wellbeing in Victoria by establishing a regulatory framework for preventing and managing the serious risk to life, public health and wellbeing presented by the outbreak or spread of pandemics and diseases of pandemic potential.
LA: 1R 26/10/21, 2R 27/10/21, 28/10/21, Passed 28/10/21
LC: 1R 28/10/21, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Subject to subsections (2), (3) and (4), this Act comes into operation on the day after the day on which it receives the Royal Assent.
- The following provisions come into operation on a day or days to be proclaimed-
(a) Part 3;
(b) Division 3 of Part 4;
(c) Division 2 of Part 5;
(d) Part 6.
- Division 2 of Part 4 comes into operation on 16 December 2021.
- If a provision mentioned in subsection (2) does not come into operation before the day that is 12 months after the day on which this Act receives the Royal Assent, it comes into operation on that day.
A Bill for An Act to establish the Victorian Collaborative Centre for Mental Health and Wellbeing, to make consequential amendments to other acts and for other purposes.
The main purposes of the Bill, are:
- to establish the Victorian Collaborative Centre for Mental Health and Wellbeing; and
- to make consequential amendments to other Acts.
LA: 1R 12/10/21, 2R 13/10/21, 26/10/21, 28/10/21, Passed 28/10/21
LC: 1R 28/10/21, 2R 28/10/21, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Subject to subsections (2) and (3), this Act comes into operation on a day or days to be proclaimed.
- If a provision of this Act (other than section 11(7) or (8)) does not come into operation before 1 October 2022, it comes into operation on that day.
- If section 11(7) or (8) does not come into operation before 1 April 2023, it comes into operation on that day.
Western Australia
A Bill for An Act to amend the Health Services Act 2016; and the Mental Health Act 2014; and the Motor Vehicle (Catastrophic Injuries) Act 2016; and the Queen Elizabeth II Medical Centre Act 1966; and the University Medical School, Teaching Hospitals, Act 1955.
The Health Services Amendment Bill 2021 (the Bill) amends the Health Services Act 2016 (the Act) to refine the Act's effectiveness. The Bill amends the functions and powers of the Minister for Health (the Minister), the Department CEO and health service providers (HSPs) to improve the functioning of the WA health system and to overcome operational and administrative burdens that have been encountered since the Act commenced. It also rectifies drafting errors and amends the parts of the Act that have not been operationalised effectively due to ambiguous interpretation.
LA: Notice of Motion 23/06/21
LA: 1R 24/06/21, 2R 24/06/21, 28/10/21, Passed TBA
LC: 1R TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act comes into operation as follows -
(a) Part 1 - on the day on which this Act receives the Royal Assent;
(b) the rest of the Act - on a day fixed by proclamation, and different days may be fixed for different provisions.
Return to top
New Acts
Federal
National Disability Insurance Scheme Amendment (Improving Supports for At Risk Participants) Act 2021
An Act to amend the National Disability Insurance Scheme Act 2013, and for related purposes
The NDIS Act 2013 (the NDIS Act) provides a foundation for measures to support and protect NDIS participants at risk of harm. This Act amends various provisions in the NDIS Act to improve the support and protections provided to NDIS participants who may be at risk of harm.
Following recent cases of abuse, neglect and exploitation of NDIS participants, the Government has considered a number of inquiries the effectiveness of NDIS safeguards in these cases, in addition to the Hon. Alan Robertson SC Independent Review of the adequacy of the regulation of the supports and services provided to Ms Ann- Marie Smith, an NDIS Participant, who died on 6 April 2020 (the Robertson Review), commissioned by the NDIS Commissioner.
The Act will strengthen support and protections for people with disability by ensuring a clear and effective legislative basis for the NDIS Quality and Safeguards Commissioner's (Commissioner's) powers, compliance and enforcement arrangements, provider registration provisions and efficient information sharing across governments and government agencies.
On 17 Jun 2021, the Senate Selection of Bills Committee referred the Bill to the Community Affairs Legislation Committee for inquiry and report by 12 August 2021.
Reps: Intro 03/06/21, 2R 03/06/21, 23/08/21, 24/08/21, 25/08/21, Passed 25/08/21
Senate: Intro 26/08/21, 2R 19/10/21, 20/10/21, Passed 21/10/21
Assent 28/10/21, Act No. 116 of 2021.
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
Return to top